Not sure what you're referencing in those first 2 sections. I've never been in a clinical trail or discussed slowed enrollment. Maybe that was for the other guy?
I deleted my previous post because I couldn't confirm if it was 15 patients or 21 patients on August 2nd for EAP.
You’re right — and here’s the video. Dr. Javitt mentions that, unfortunately, “patients die before they can receive the medication.”
There have been LOTS of requests for it by the sounds of things, and I agree they must have more data from patients who were treated under the EAP.
So..... the EUA will be incredible and super necessary because then NeuroRX doesn’t have to work with EACH hospital individually, get the patient the treatment, etc (and meanwhile some DIE.... very sad).
EUA on RLF-100 / Aviptadil just in the “critical care stage” alone will save many many lives.
As Dr. Javitt says here, it will then just be a matter of the hospital calling the pharmacy and requesting the medication.
Video here:
I was reading today that the American Gov gave like $1.2bln to Eli Lilly to produce TONS of their vaccine. Now it’s paused (and I read that might not be all bad either necessarily)..... but that gives us a pretty clear idea of the $$$ going into Vaccines and Therapeutics since Governments are throwing darts trying to hit a winner.
Same case should be with RLFTF. As soon as this gets more exposure, possibly as early as tomorrow depending on WHAT Dr. Javitt delivers, look out for mega mega Gov $$$ to scale up this treatment further !!!
News 
Market Data 
Discover 
AI
